Rheumatology

Guidelines (9)

Certolizumab Pegol for Treating Rheumatoid Arthritis after Inadequate Response to a TNF-Alpha Inhibitor (TA415)

26 October 2016

Care and Management of Osteoarthritis in Adults (NICE Guideline)

15 March 2014

Summary of NICE guidance on OA assessment and treatment.

Pegloticase for Treating Severe Debilitating Chronic Tophaceous Gout (TA291)

26 June 2013

Abatacept for Treating Rheumatoid Arthritis After the Failure of Conventional Disease-Modifying Anti-Rheumatic Drugs (TA280)

24 April 2013

Denosumab for the Treatment of Therapy-Induced Bone Loss in Non-Metastatic Prostate Cancer (terminated appraisal) (TA194)

24 January 2013

Denosumab for the Prevention of Skeletal-Related Events in Adults with Bone Metastases from Solid Tumours (TA265)

24 October 2012

Tocilizumab for the Treatment of Rheumatoid Arthritis (TA247)

26 March 2012

Denosumab for the Prevention of Osteoporotic Fractures in Postmenopausal Women (TA204)

31 October 2010

Febuxostat for the Management of Hyperuricaemia in People with Gout (TA164)

14 April 2010

Tables (1)

Table: Calcium and Vitamin D Supplements for Osteoporosis

22 October 2018

Formulations, doses and costs of osteoporosis supplements.

Drug Sections (6)

Rheumatology in the News

Diclofenac significantly increases cardiovascular risk, large study suggests

By Chloe Harman, 6 September 2018

The authors of a large-scale safety study of diclofenac...

Calcium and Vitamin D Supplements for Osteoporosis

16 August 2018